Prediction: 2026 Will Be the Year of Eli Lilly [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has behaved more like a tech stock in recent years than like a pharma stock. Tech players are known to soar in the double and triple digits when the environment and corporate news are supportive. Pharmaceutical companies generally take a slower but steady path, and this is due to the fact that patients always need their medicines -- this supports revenue stability over time. So, why has Lilly become a growth stock? The company has established leadership in an area of high demand: the weight loss drug market. Lilly sells tirzepatide, sold under the name Mounjaro for type 2 diabetes and Zepbound for weight loss. Together, these drugs delivered more than $10 billion in revenue in the latest quarter and helped the company's overall revenue soar in the double digits. I think this momentum is far from over. In fact, my prediction is that 2026 will be the year of Eli Lilly. And this is for one specific reason... As ment
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancerPR Newswire
- Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus [MSNBC.com]MSNBC.com
- What Eli Lilly (LLY)'s NVIDIA AI Lab And Obesity Data Reveal About Its Obesity Leadership Narrative [Yahoo! Finance]Yahoo! Finance
- Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? [Yahoo! Finance]Yahoo! Finance
- BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website